2013
DOI: 10.1016/j.jaci.2013.03.034
|View full text |Cite
|
Sign up to set email alerts
|

A focused parameter update: Hereditary angioedema, acquired C1 inhibitor deficiency, and angiotensin-converting enzyme inhibitor–associated angioedema

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

2
177
0
22

Year Published

2014
2014
2024
2024

Publication Types

Select...
4
3

Relationship

0
7

Authors

Journals

citations
Cited by 153 publications
(201 citation statements)
references
References 136 publications
2
177
0
22
Order By: Relevance
“…AAE might be the presenting symptom [5]. Rarely, nonlymphoproliferative diseases were reported to be associated with AAE, mostly systemic lupus erythematosus, acute hepatitis B infection, and human immunodeficiency virus infection [7,8]. Whereas HAE results from low levels or an abnormal function of the serine protease C1 esterase inhibitor, AAE entails the enhanced catabolism of the C1INH, sometimes associated with C1INH autoantibodies.…”
Section: Commentarymentioning
confidence: 99%
See 1 more Smart Citation
“…AAE might be the presenting symptom [5]. Rarely, nonlymphoproliferative diseases were reported to be associated with AAE, mostly systemic lupus erythematosus, acute hepatitis B infection, and human immunodeficiency virus infection [7,8]. Whereas HAE results from low levels or an abnormal function of the serine protease C1 esterase inhibitor, AAE entails the enhanced catabolism of the C1INH, sometimes associated with C1INH autoantibodies.…”
Section: Commentarymentioning
confidence: 99%
“…Although ecallantide and icatibant are not FDA-approved for acute attacks in AAE patients, both drugs have been reported to be efficacious for in this setting [9]. AAE patients may be less responsive to androgens and experience more efficiency of antifibrinolytic treatment compared to HAE patients [7]. Most importantly, when possible, the underlying disorder should be treated.…”
Section: Commentarymentioning
confidence: 99%
“…Various types of mutations in the C1-INH gene result in diminished levels or function of C1-INH protein (HAE type I) or normal or elevated levels of C1-INH, which is not fully functional (HAE type II). 2 Type III is less common, and therefore not as well known. Unlike type I and II, there is no change in C1-INH level or functionality in HAE type III, yet similar symptoms are present.…”
mentioning
confidence: 99%
“…Bunlar anabolik steroidler, antifibrinolitikler ve C1 inhibitörlerdir (15). Biz olgumuzda traneksamik asid tercih ettik.…”
unclassified
“…Bu tedavi yaklaşımına, kısa süreli profilaksi denilmektedir (15). Hiç bir olgumuzda kısa süreli tedavi kullanmak zorunda kalmadık.…”
unclassified